Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026

Rhea-AI Summary

Insmed (Nasdaq: INSM) will release first-quarter 2026 financial results on Thursday, May 7, 2026 and host a conference call at 8:00 a.m. ET that day. Management will discuss financial results and provide a business update.

The live call will be webcast at www.insmed.com; a replay will be available by phone through May 14, 2026 and archived on the investor site for 90 days.

News Market Reaction – INSM

-0.45%

35 alerts

-0.45% Session close to close

-2.2% Trough in 5 hr 52 min

$29.72B Market Cap

0.8x Rel. Volume

In the Apr 23 session, INSM declined 0.45%, reflecting a mild negative market reaction. Argus tracked a trough of -2.2% from its starting point during tracking. Our momentum scanner triggered 35 alerts that day, indicating elevated trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timing for Insmed’s Q1 2026 results and business update on May 7, 2026 at...

Analysis

This announcement sets the timing for Insmed’s Q1 2026 results and business update on May 7, 2026 at 8:00 a.m. ET. Historically, similar “conferences,earnings” notices have produced small price moves, with an average reaction of -0.48%. Key considerations will come from the actual results: progress versus prior revenue guidance, any updates on clinical programs, and how management frames upcoming 2026 milestones.

Key Figures

Results date: May 7, 2026 Call time: 8:00 a.m. ET Replay end date: May 14, 2026 +5 more

8 metrics

Results date May 7, 2026 First-quarter 2026 financial results release

Call time 8:00 a.m. ET Start of Q1 2026 conference call

Replay end date May 14, 2026 Telephone replay availability for the call

Webcast archive length 90 days Duration call replay remains on company website

Access code 7862189 Investor conference call dial-in code

US dial-in (888) 210-2654 Domestic access number for live call

International dial-in (646) 960-0278 International access number for live call

Market cap 30430835966 Pre-news market capitalization

Previous Conferences,earnings Reports

5 past events · Latest: Feb 05 (Neutral)

Same Type Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 05	Earnings call notice	Neutral	-0.9%	Scheduled Q4 and full-year 2025 results call with standard access details.
Oct 15	Earnings call notice	Neutral	+1.3%	Announced Q3 2025 results release and investor call timing and access info.
Jul 24	Earnings call notice	Neutral	+0.1%	Set date and time for Q2 2025 financial results and webcasted call.
Apr 23	Earnings call notice	Neutral	-0.6%	Outlined Q1 2025 results release date and investor conference call logistics.
Feb 10	Earnings call notice	Neutral	-2.3%	Announced Q4 and full-year 2024 results timing and related investor call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior conference-call scheduling headlines tagged “conferences,earnings” have led to modest stock moves, with an average 24-hour reaction of -0.48%, suggesting these notices are typically low-impact events.

Recent Company History

Recent “conferences,earnings” headlines show a consistent pattern of Insmed announcing quarterly and full-year results dates with associated investor calls at 8:00 a.m. ET. Announcements on Feb 20, 2025, May 8, 2025, Aug 7, 2025, Oct 30, 2025, and Feb 19, 2026 all followed this template, including dial-in numbers, access code 7862189, and 90-day webcast archives. Price reactions around these notices have been small and mixed, reinforcing their informational nature.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BRIDGEWATER, N.J., April 23, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its first-quarter 2026 financial results on Thursday, May 7, 2026.

Insmed management will host a conference call for investors beginning at 8:00 a.m. ET on Thursday, May 7, 2026, to discuss financial results and provide a business update.

Shareholders and other interested parties may participate in the conference call by dialing (888) 210-2654 (U.S.) and (646) 960-0278 (international) and referencing access code 7862189. The call will also be webcast live on the Company's website at www.insmed.com.

A replay of the conference call will be accessible approximately 1 hour after its completion through May 14, 2026, by dialing (800) 770-2030 (U.S.) and (609) 800-9909 (international) and referencing access code 7862189. A webcast of the call will also be archived for 90 days under the Investor Relations section of the Company's website at www.insmed.com.

About Insmed

Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including two therapies approved to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.

Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending five consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more or follow us on LinkedIn, Instagram, YouTube, and X.

Contact:

Investors:

Bryan Dunn
Vice President, Investor Relations
(646) 812-4030
investor.relations@insmed.com

Media:

Claire Mulhearn
Vice President, Corporate Communications
(862) 842-6819
media@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-host-first-quarter-2026-financial-results-conference-call-on-thursday-may-7-2026-302750941.html

SOURCE Insmed Incorporated

FAQ

When will Insmed (INSM) release first-quarter 2026 results and hold the conference call?

Insmed will release first-quarter 2026 results and host a call on May 7, 2026 at 8:00 a.m. ET. According to Insmed, management will discuss financial results and provide a business update during the conference call on that date.

How can investors join the Insmed (INSM) Q1 2026 conference call on May 7, 2026?

Investors can join by dialing (888) 210-2654 (U.S.) or (646) 960-0278 (international) with access code 7862189. According to Insmed, the call will also be available via live webcast on the company website.

Will there be a replay or archived webcast of the Insmed (INSM) May 7, 2026 conference call?

A phone replay will be available through May 14, 2026 using access code 7862189, and a webcast archive will remain on the investor site for 90 days. According to Insmed, the replay will be accessible about one hour after the call ends.

What topics will Insmed (INSM) management cover on the Q1 2026 earnings call?

Management will discuss the company's first-quarter 2026 financial results and provide a business update during the call. According to Insmed, the presentation is intended to review results and offer current operational context to investors and stakeholders.

Where can I find the live webcast and archived recording for Insmed (INSM) Q1 2026 results?

The live webcast and archived recording are available at www.insmed.com under Investor Relations; the archive will remain for 90 days. According to Insmed, investors may access the live stream during the May 7, 2026 call and the archived file afterward.